These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25117073)
1. Expression of HSPA2 in human hepatocellular carcinoma and its clinical significance. Fu Y; Zhao H; Li XS; Kang HR; Ma JX; Yao FF; Du N Tumour Biol; 2014 Nov; 35(11):11283-7. PubMed ID: 25117073 [TBL] [Abstract][Full Text] [Related]
2. Overexpression of HSPA2 is correlated with poor prognosis in esophageal squamous cell carcinoma. Zhang H; Chen W; Duan CJ; Zhang CF World J Surg Oncol; 2013 Jun; 11():141. PubMed ID: 23777267 [TBL] [Abstract][Full Text] [Related]
3. Expression and clinical significance of HSPA2 in pancreatic ductal adenocarcinoma. Zhang H; Gao H; Liu C; Kong Y; Wang C; Zhang H Diagn Pathol; 2015 Mar; 10():13. PubMed ID: 25890028 [TBL] [Abstract][Full Text] [Related]
4. Differential expression of IQGAP1/2 in Hepatocellular carcinoma and its relationship with clinical outcomes. Xia FD; Wang ZL; Chen HX; Huang Y; Li JD; Wang ZM; Li XY Asian Pac J Cancer Prev; 2014; 15(12):4951-6. PubMed ID: 24998570 [TBL] [Abstract][Full Text] [Related]
5. High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy. Wang H; Jiang S; Zhang Y; Pan K; Xia J; Chen M World J Surg Oncol; 2014 Jul; 12():226. PubMed ID: 25037578 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of ARK5 is associated with poor prognosis in hepatocellular carcinoma. Cui J; Yu Y; Lu GF; Liu C; Liu X; Xu YX; Zheng PY Tumour Biol; 2013 Jun; 34(3):1913-8. PubMed ID: 23516026 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of BMP7 as an oncogene in hepatocellular carcinoma. Li W; Cai HX; Ge XM; Li K; Xu WD; Shi WH Tumour Biol; 2013 Apr; 34(2):669-74. PubMed ID: 23179403 [TBL] [Abstract][Full Text] [Related]
8. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma. Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279 [TBL] [Abstract][Full Text] [Related]
9. Expression of cytoskeleton regulatory protein Mena in human hepatocellular carcinoma and its prognostic significance. Hu K; Wang J; Yao Z; Liu B; Lin Y; Liu L; Xu L Med Oncol; 2014 May; 31(5):939. PubMed ID: 24683008 [TBL] [Abstract][Full Text] [Related]
10. Suppression of SAMSN1 Expression is Associated with the Malignant Phenotype of Hepatocellular Carcinoma. Sueoka S; Kanda M; Sugimoto H; Shimizu D; Nomoto S; Oya H; Takami H; Ezaka K; Hashimoto R; Tanaka Y; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1453-60. PubMed ID: 25805236 [TBL] [Abstract][Full Text] [Related]
11. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174 [TBL] [Abstract][Full Text] [Related]
12. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
13. IMP3 combined with CD44s, a novel predictor for prognosis of patients with hepatocellular carcinoma. Hu S; Wu X; Zhou B; Xu Z; Qin J; Lu H; Lv L; Gao Y; Deng L; Yin J; Li G J Cancer Res Clin Oncol; 2014 Jun; 140(6):883-93. PubMed ID: 24647926 [TBL] [Abstract][Full Text] [Related]
14. Extracellular HSP70-peptide complexes promote the proliferation of hepatocellular carcinoma cells via TLR2/4/JNK1/2MAPK pathway. Zhe Y; Li Y; Liu D; Su DM; Liu JG; Li HY Tumour Biol; 2016 Oct; 37(10):13951-13959. PubMed ID: 27492456 [TBL] [Abstract][Full Text] [Related]
15. Effects of miR-152 on cell growth inhibition, motility suppression and apoptosis induction in hepatocellular carcinoma cells. Dang YW; Zeng J; He RQ; Rong MH; Luo DZ; Chen G Asian Pac J Cancer Prev; 2014; 15(12):4969-76. PubMed ID: 24998573 [TBL] [Abstract][Full Text] [Related]
16. Low CDX1 expression predicts a poor prognosis for hepatocellular carcinoma patients after hepatectomy. Zheng H; Yang Y; Wang MC; Yuan SX; Tian T; Han J; Ni JS; Wang J; Xing H; Zhou WP Surg Oncol; 2016 Sep; 25(3):171-7. PubMed ID: 27566019 [TBL] [Abstract][Full Text] [Related]
17. Roles of fibroblast growth factor-inducible 14 in hepatocellular carcinoma. Li N; Hu WJ; Shi J; Xue J; Guo WX; Zhang Y; Guan DX; Liu SP; Cheng YQ; Wu MC; Xie D; Liu SR; Cheng SQ Asian Pac J Cancer Prev; 2013; 14(6):3509-14. PubMed ID: 23886137 [TBL] [Abstract][Full Text] [Related]
18. Low levels of glycoprotein 96 indicate a worse prognosis in early-stage hepatocellular carcinoma patients after hepatectomy. Ji F; Zhang Y; Zhu ZB; Guo Y; Shen SL; Cao QH; Li SQ; Peng BG; Liang LJ; Hua YP Hum Pathol; 2019 Apr; 86():193-202. PubMed ID: 30529751 [TBL] [Abstract][Full Text] [Related]
19. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma. Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591 [TBL] [Abstract][Full Text] [Related]
20. Chromobox homolog 4 is correlated with prognosis and tumor cell growth in hepatocellular carcinoma. Wang B; Tang J; Liao D; Wang G; Zhang M; Sang Y; Cao J; Wu Y; Zhang R; Li S; Ding W; Zhang G; Kang T Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S684-92. PubMed ID: 23943028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]